Journey Medical Corp (DERM): Gross Profit
$40.31M
Year ended 2025-12-31
$43.30M
Trailing 12 months to 2026-06-30
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.31M | +17.7% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $34.26M | -6.8% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $36.77M | n/c | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $40.22M | +29.5% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $31.05M | +3.7% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $29.94M | n/a | 2022-03-28, From 2020-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Journey Medical Corp (DERM) | 2025-12-31 | $40.31M | +17.7% |
| Nuvation Bio Inc. (NUVB) | 2024-12-31 | $795.0K | n/a |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $42.34M | +15.1% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $36.82M | -19.7% |
| Nektar Therapeutics (NKTR) | 2024-12-31 | $67.74M | +20.2% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $11.70M | -33.1% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $47.68M | +47.5% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $45.38M | -21.9% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $42.74M | +82.6% |
Compare DERM, NUVB, FBIO, AYTU side by side · Screen every company in Pharmaceutical Preparations ↗